OR WAIT null SECS
April 03, 2023
As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.
March 22, 2023
In addition to a new interim president, the company is opening new microbial capacity at its San Antonio facility and has plans to construct a commercial-scale facility in Manhattan, Kan.
March 08, 2023
Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.
March 02, 2023
The trends shaping the growth of the biologics outsourcing industry demand attention.
The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.
February 22, 2023
Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.
February 16, 2023
To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
February 15, 2023
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.
Growth in outsourcing has been the result of COVID-19 projects taking precedence, which has pushed some contract manufacturing to second-tier CDMOs.
February 13, 2023
The technology is designed to enable patients to self-inject biologic-based therapies at home instead of a hospital setting.